TradingView
chartmojo
19 Sep 2016 pukul 19.25

SRPT regression play Singkat

Sarepta Therapeutics, Inc.NASDAQ

Huraian

100% pop should regress some

Komen

important Duchens Muscular Dystrophy reversal/approval..small market however

Komen

Frankly after researching this companies drug and Duchenne Muscular Dystrophy i find myself rooting for this company. This stock popped some 95% on an approval of their drug that delays the onset of the debilitating effects of this little known genetic disease in children. While there was and may be more regression opportunities in the price from a technical perspective, especially for a scalper like me, I'm hoping the company's stock actually ultimately goes to the moon and that those dedicated individuals involved in this company prosper because they deserve it.
Komen
INIFINIT3LIGHT
Hi Can you please tell me how to add UCS_SMI and CCMI_LB indicators?
Lebih